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The intranuclear assembly of herpesvirus subviral particles remains an incompletely understood process.
Previous studies have described the nuclear localization of capsid and tegument proteins as well as intranu-
clear tegumentation of capsid-like particles. The temporally and spatially regulated replication of viral DNA
suggests that assembly may also be regulated by compartmentalization of structural proteins. We have
investigated the intranuclear location of several structural and nonstructural proteins of human cytomegalo-
virus (HCMV). Tegument components including pp65 (ppUL83) and ppUL69 and capsid components includ-
ing the major capsid protein (pUL86) and the small capsid protein (pUL48/49) were retained within the
nuclear matrix (NM), whereas the immediate-early regulatory proteins IE-1 and IE-2 were present in the
soluble nuclear fraction. The association of pp65 with the NM resisted washes with 1 M guanidine hydrochlo-
ride, and direct binding to the NM could be demonstrated by far-Western blotting. Furthermore, pp65
exhibited accumulation along the nuclear periphery and in far-Western analysis bound to proteins which
comigrated with proteins of the size of nuclear lamins. A direct interaction between pp65 and lamins was
demonstrated by coprecipitation of lamins in immune complexes containing pp65. Together, our findings
provide evidence that major virion structural proteins localized to a nuclear compartment, the NM, during
permissive infection of human fibroblasts.
Recent studies have indicated that the human cytomegalo-
virus (HCMV) virion is composed of a larger number of pro-
teins than previously thought, suggesting that assembly of the
infectious particle is extraordinarily complex (3). The descrip-
tion of the architecture of the virion has been simplified to
include three distinct structures: the capsid, the envelope, and
a poorly characterized region between the capsid and envelope
termed the tegument (54, 55). The protein composition of the
HCMV tegument has been incompletely defined, but it is
thought to be composed of a large number of phosphoproteins
(3, 46). Although there is general agreement that the capsid is
assembled in the nucleus, considerable controversy continues
to surround the identity of the cellular site of envelopment of
herpesviruses (4, 19, 30, 53). The assembly pathway of the
tegument region remains even less well understood. The dis-
tribution of protein components of the HCMV tegument sug-
gests that assembly of this virion structure takes place in both
the nucleus and the cytoplasm. Tegument proteins encoded by
UL82 (pp71), UL83 (pp65), and UL69 open reading frames
appear to localize in the nucleus, while the tegument protein
pp28 (ppUL99) is detected in extranuclear compartments of
infected cells (24, 26, 38, 58, 61). HCMV pp150 (UL32) has
been reported to demonstrate both a nuclear and a cytoplas-
mic distribution (34), although studies in our laboratory have
suggested that pp150 is predominantly a cytoplasmic protein
(58). This organization of tegument components suggests that
these proteins are incorporated into the virion in an ordered
manner and, furthermore, that understanding tegument mor-
phogenesis could provide insight into the pathways of virion
assembly and nuclear egress.
To further describe virion maturation, we have begun an
investigation of the pathway in which the tegument is assem-
bled around the nucleocapsid. Recent studies of herpes sim-
plex virus (HSV) together with previous reports describing
replication centers in the nuclei of infected cells have sug-
gested that herpesviruses not only employ complex regulatory
controls of transcription and replication (18, 41, 42, 56) but
possibly regulate particle assembly by localizing structural pro-
teins into discrete subnuclear compartments (63, 64). Recent
studies by Ward and coworkers have divided the nucleus of
HSV-infected cells into different compartments called assem-
blons based on localization of known proteins of HSV (64).
These included compartments for replication and subviral par-
ticle formation (64). We have begun a series of experiments to
further define the assembly and nuclear egress of HCMV.
Specifically, we have examined the distribution of several teg-
ument proteins within the nuclear matrix of infected cells in
order to define spatial relationships and potential colocaliza-
tion of structural proteins late in infection. This compartment
of the nucleus was examined initially because it has been de-
fined biochemically and thus represented a nuclear compart-
ment which could be analyzed by both biochemical and imag-
ing techniques.
The nuclear matrix is a proteinaceous network which is
tightly associated with the inner nuclear membrane. In many
cell systems, the nuclear matrix has been found to be the site of
active transcription and replication of cellular DNA (6, 28, 35,
48, 49, 62). Proteins involved in these processes as well as those
with regulatory roles in cell division localize to this nuclear
scaffold (8, 15, 22, 32, 39, 40, 43, 52). Among DNA viruses,
there are numerous examples of viral gene products which
associate with the nuclear matrix or nuclear matrix structures
(2, 10, 14, 16, 21, 25, 31, 37, 44, 51, 60, 66). This association may
serve to compartmentalize products necessary for efficient
transcription and replication of the viral genome or to seques-
ter components involved in virion maturation (5, 7, 25, 37, 44,
51, 66). The role of the nuclear matrix in the replicative cycle
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of herpesviruses, including HCMV, has not been extensively
studied. In this report we have described the binding of several
HCMV virion structural proteins including pp65 (ppUL83),
ppUL69, and the major capsid protein (MCP; pUL86) to the
nuclear matrix of HCMV-infected cells. The accumulation of
virion components on the nuclear matrix late in infection sug-
gested that this compartment was a potential staging site for
virion structural proteins prior to their assembly into subviral
particles.
MATERIALS AND METHODS
Cells, viruses, and antibodies. Human foreskin fibroblasts (HF) and monkey
BSC-1 cells were maintained in medium 199 with 5% newborn calf serum and
antibiotics at 37°C. For in situ nuclear matrix extractions, HF were grown on
glass coverslips at 37°C in 5% CO2. Cells were infected with the AD169 strain of
HCMV at a multiplicity of infection of 0.1 to 1. The human epidermoid carci-
noma cell line HEp-2 and monkey Cos7 cells were maintained at 37°C in 5% CO2
in Dulbecco’s modified Eagle medium supplemented with 10% fetal calf serum
and antibiotics.
The recombinant vaccinia viruses vv-Eco V gB and vv-pp65 were propagated
in BSC-1 cells. The construction and characterization of these recombinant
vaccinia viruses have been reported elsewhere (9, 13). The vv-Eco V gB construct
differs from the vv-gB recombinant previously reported in that it contains the gB
gene of AD169 truncated at nucleotide 1950 and the corresponding gB protein
terminates at amino acid 650. This protein lacks the carboxy terminus including
the transmembrane region and represents a secreted form of HCMV gB. The
pp65-green fluorescent protein fusion was constructed by using the EGFP-N2
plasmid (Clontech, Palo Alto, Calif.). A BamHI site was generated at the 59 end
of the pp65 genomic sequence by PCR using the primer 59 TTTTTTGGATCC
ATGGAGTCGCGCGGT 39. The product was fused in frame into the EGFP-N2
vector 39 to the enhanced green fluorescence protein (EGFP) coding sequence.
HCMV proteins were detected with monoclonal antibodies (MAbs) previously
described (1, 12, 50, 65). The MAbs used in this study include those with specific
reactivity to IE-1 (p63-27), IE-2 (IE-2-9-5), pp65 (28-19, 65-8, 28-103, 28-77),
MCP (28-4), the small capsid protein (SCP) (11-2-23), gB (7-17), UL69 (UL69),
UL44 (28-21), and pp28 (41-18). The guinea pig polyclonal serum recognizing
pp65 was generated by repeated immunization of guinea pigs with pp65 purified
from bacteria. The previously characterized rabbit polyclonal antibody 237
against lamins a, b, and c was a generous gift from Robert Goldman (Depart-
ment of Cell and Molecular Biology, Northwestern University School of Medi-
cine) (29). The rabbit polyclonal sera against lamins a and c and against lamin b
(17) were a generous gift from Nilabh Chaudhary (RPI, Boulder, Colo.). The
MAb against lamin B1, NA12, was purchased from Oncogene Sciences (Boston,
Mass.). Fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse immu-
noglobulin G (IgG) and FITC-conjugated goat anti-guinea pig IgG antibodies
were obtained from Cappell Laboratories (Raleigh, N.C.). Texas red-conjugated
goat anti-rabbit IgG antibody was purchased from Southern Biotechnology As-
sociates (Birmingham, Ala.).
Preparation of nuclear matrix. Nuclear matrix fractions were prepared by a
method similar to that described by Mirkovitch et al. (45). AD169-infected HF,
vv-pp65 and vv-Eco V gB-infected BSC-1 cells, or uninfected HEp-2 cells were
fractionated by extraction in 0.1 or 0.2% Nonidet P-40 (NP-40) in phosphate-
buffered saline (PBS; 137 mM NaCl, 8.1 mM NaH2PO4 z 12H2O, 2.7 mM KCl,
1.8 mM KH2PO4 [pH 7.4]) to yield crude nuclei. Nuclei were resuspended in 1
ml of digestion buffer (20 mM Tris-HCl [pH 7.4], 20 mM KCl, 70 mM NaCl, 10
mM MgCl2, 0.05 mM spermine, 0.125 mM spermidine) with 1 mM phenylmeth-
ylsulfonyl fluoride (PMSF) and subjected to digestion with DNase I (0.05 mg/ml)
for 15 min at room temperature. Nuclei were then resuspended in digestion
buffer with 0.1% digitonin and incubated at room temperature for 10 min. The
nuclear material was pelleted and then extracted in high-salt buffer (2 M NaCl,
20 mM HEPES [pH 7.4], 20 mM EDTA) on ice for 5 min. The nuclear material
was then pelleted and washed twice in digestion buffer and finally resuspended in
sodium dodecyl sulfate (SDS) sample buffer with 5% 2-mercaptoethanol or
washed three times in 1 M guanidine hydrochloride in digestion buffer (2 min per
wash) before addition of sample buffer (25). For a typical experiment, six 150-
cm2 flasks of AD169-infected HF were harvested. For quantitative Western
blots, AD169-infected HF cells from 14 150-cm2 flasks were fractionated and
protein content was determined by using bicinchoninic acid reagent (Pierce,
Rockford, Ill.). The radioactive signal was quantitated on a Molecular Dynamics
PhosphorImager. For far-Western blots, nuclear matrix fractions were isolated
from four 150-cm2 flasks of HEp-2 cells.
Nuclear matrix extracts for immunoprecipitation were prepared by a method
similar to that described by Fey and Penman (23). Briefly, the nuclear matrix
material extracted from AD169-infected cells was solubilized in disassembly
buffer (8 M urea, 20 mM morpholineethanesulfonic acid [pH 6.6], 1 mM EGTA,
1 mM PMSF, 0.1 mM MgCl2, 1% 2-mercaptoethanol) for 16 h at 4°C. The
insoluble material was removed by centrifugation. The urea was removed from
the supernatant by step dialysis against Tris-buffered saline (TBS; 50 mM Tris-
HCl, 150 mM NaCl, 1 mM EDTA, pH 7.4) at 4°C, and the insoluble material was
removed at each step. A mixture of three pp65-specific MAbs (28-19, 28-103, and
65-8) was used to precipitate the dialyzed extract. Immunoprecipitates were
collected on protein A-agarose and washed extensively in radioimmunoprecipi-
tation assay buffer (1% NP-40, 1% deoxycholate, and 0.2% SDS in TBS [pH
7.4]). The samples were subjected to SDS-polyacrylamide gel electrophoresis
(PAGE) and then transferred to nitrocellulose for Western blotting as described
previously (12).
For in situ extraction of AD169-infected HF, a different method was used for
nuclear matrix preparation. This method was similar to that described by He et
al. (33). Infected monolayers grown on glass coverslips were treated with diges-
tion buffer (described above) with 0.1 mM PMSF and 0.5% NP-40 for 3 to 5 min
on ice. The monolayers were then treated with digestion buffer containing DNase
I (0.05 mg/ml) for 15 min at room temperature. Chromatin was removed by
washing monolayers three times with 0.25 M ammonium sulfate in digestion
buffer (pH 7.2) at room temperature, 10 min per wash. Cells were then extracted
with high-salt buffer (described above) for 5 min on ice. Cell cytoskeletons were
carefully rinsed with digestion buffer and then fixed in 2.5% paraformaldehyde in
PBS for 20 min at room temperature.
Fluorescence microscopy. Virus-infected HF grown on glass coverslips were
fixed in 2.5% paraformaldehyde in PBS and permeabilized with 0.2% Triton
X-100 in PBS for 5 min. After rinsing, cells and extracted cytoskeletons were
blocked with 30% goat serum in PBS for 30 min at 37°C. Coverslips were
incubated with primary antibody with 1% goat serum for 1 h at 37°C. Coverslips
were washed three times in PBS, 5 min per wash, and then incubated with
FITC-conjugated and/or Texas red-conjugated secondary antibody for 1 h at
37°C. After washing, coverslips were refixed with 0.5% paraformaldehyde in PBS
for 10 min. After rinsing in PBS, coverslips were mounted with SlowFade anti-
fade reagent (Molecular Probes, Eugene, Oreg.), sealed with fingernail polish,
and viewed on a Leitz Diavert fluorescence microscope or a Zeiss confocal
microscope.
Cos7 cells grown on coverslips were transfected by either the Lipofectin (57)
or calcium phosphate (59 Prime-39 Prime, Boulder, Colo.) protocol. Cells were
transfected with a modified pcDNA3 vector (Invitrogen, San Diego, Calif.)
containing the pp65 genomic sequence or a vector encoding a green fluorescent
protein-pp65 fusion protein (Clontech). Transfected cells were fixed 36 to 48 h
posttransfection, and cells expressing pp65 were reacted with MAb 28-19 fol-
lowed by FITC-conjugated goat anti-mouse IgG antibody as described above.
Far-Western blots. pp65 was purified from Escherichia coli transformed with
the plasmid trc/hisA (Invitrogen), which contained the complete pp65 open
reading frame. After induction with isopropylthio-b-D-galactopyranoside, cul-
tures were collected and the bacterial pellet was resuspended in denaturing lysis
buffer (20 mM Tris-HCl, 100 mM NaCl, 8 M urea [pH 8.0]). The suspension was
sonicated on ice until translucent. Insoluble material was removed by centrifu-
gation at 10,000 3 g for 10 min. The lysate was incubated with Talon metal
affinity resin (Clontech) at room temperature with gentle rocking for 30 min. The
resin was collected by centrifugation and washed with denaturing lysis buffer
three times, 10 min per wash. pp65 was eluted by incubating the resin with
denaturing lysis buffer containing 75 mM imidazole four times, 10 min per
elution. Fractions were pooled, and the urea was removed by dialysis against
TBS. Protein concentration was determined by using bicinchoninic acid reagent
(Pierce).
Nuclear matrix samples from HEp-2 cells were subjected to SDS-PAGE as
previously described (12). Proteins were blotted to nitrocellulose, and filters were
blocked in 5% dry milk in PBS. Strips were incubated with 150 to 200 mg of pp65
per strip in 5% milk overnight at room temperature with gentle rocking (2). The
strip was washed in PBS three times, 10 min per wash; following the final wash,
it was incubated with the pp65-specific MAb 28-19 for 4 h at 37°C and then
washed in PBS as described above. The strip was then incubated with a rabbit
anti-mouse IgG secondary antibody for 1 h at 37°C. The filter was washed again
and then incubated with 125I-protein A for 30 min at 37°C. After washing, filters
were dried and mounted, and bound antibody was detected by autoradiography.
For Western blot analysis, nuclear matrix samples were separated electrophoreti-
cally and then blotted. Strips were processed as previously described (12).
RESULTS
Tegument and capsid protein components of HCMV are
associated with the nuclear matrix. Phosphoprotein 65 (pp65)
is one of the most abundant protein components of extracel-
lular virions and dense bodies. Shortly after HCMV infection
of human fibroblasts, pp65 can be detected in the nucleus of
infected cells, suggesting that it is actively transported to this
cellular compartment (26, 61). Immunofluorescence micros-
copy of AD169-infected HF as well as of Cos7 cells transfected
with a plasmid containing the pp65 genomic sequence revealed
the accumulation of pp65 into discrete structures in the nu-
cleus (Fig. 1A to D). Similarly, in studies utilizing a pp65-green
fluorescent protein fusion, we observed compartmentalization
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of the protein as well as focal accumulation along the periphery
of the nucleus (Fig. 1E and F). Together with previously re-
ported findings which indicated that deletion mutants of pp65
lacking the carboxy-terminal nuclear targeting signals contin-
ued to accumulate in the nucleus (26, 61), these results sug-
gested that pp65 might contain additional domains which could
mediate nuclear retention by targeting the protein to a specific
nuclear structure.
To characterize the interaction of pp65 with subnuclear
structures, we investigated the binding of the protein to the
nuclear matrix of HCMV-infected HF. Extraction of isolated
nuclei with 2 M NaCl resulted in an insoluble pellet containing
pp65, as demonstrated by Western blotting using the pp65-
specific MAb 28-19 (Fig. 2A). Because pp65 was an abundant
structural protein, we examined the possibility that other virion
components were also present in the nuclear matrix. Western
blot analysis of infected cells revealed that several virion struc-
tural proteins were associated with the nuclear matrix. Struc-
tural components including the MCP (pUL86) and the tegu-
ment protein ppUL69 were also retained in the nuclear matrix
fraction. In addition, the nonstructural viral polymerase acces-
sory protein ppUL44 and previously described lower-molecu-
lar-weight forms of this protein were associated with the nu-
clear matrix fraction of infected cells. The binding of these
proteins was stable and resisted three washes with 1 M guani-
dine hydrochloride except for an observable decrease in the 50-
to 52-kDa forms of pp65 (Fig. 2B). The interaction of these
proteins was also specific, as other virus-encoded proteins pre-
viously shown to localize in the nucleus of infected cells, in-
cluding the 72-kDa IE-1 and 86-kDa IE-2, were not detected in
the nuclear matrix (Fig. 2). In addition, two cytoplasmic virion
proteins, gB (gpUL55) and pp28 (ppUL99), were not detected
in the nuclear matrix of infected cells (Fig. 2).
The presence of structural components of the capsid and
tegument on the nuclear matrix suggested that this nuclear
structure was a potential assembly site for subviral structures.
Furthermore, the strength of the association between viral and
cellular proteins of the nuclear matrix as reflected by their
binding following washes with 1 M guanidine hydrochloride
suggested a direct interaction between individual virion pro-
teins and components of the nuclear matrix. Alternatively,
individual virion structural proteins could be tethered to the
matrix through interactions with other virus-encoded proteins.
To gauge the relative strength of these protein-protein inter-
actions, we measured the quantity of pp65 distributed between
the different pools collected during the fractionation proce-
dure (Fig. 3). As shown in Fig. 3B and Table 1, only a small
amount of the total cellular pp65 can be detected in the soluble
fraction isolated by treatment of cells with 0.2% NP-40. This
fraction contained the cytoplasm and nuclear proteins released
by this treatment, as demonstrated by the presence of IE-1 in
Fig. 3A. The nuclear and nuclear matrix fractions contained
more pp65 per microgram of protein than the soluble fraction
(Fig. 3B; Table 1). In addition, quantitation of signal intensity
showed that the relative amount of pp65 was not greatly re-
duced by the fractionation procedure (Fig. 3B, lanes 2 to 4;
Table 1). In fact, there was a relative enrichment of pp65 on
the nuclear matrix and in the guanidine hydrochloride-washed
pellet (Table 1). Of interest was the apparent loss of the 50-
FIG. 1. HCMV pp65 is a nuclear protein that is detected in subnuclear structures. HF were grown on coverslips and infected with AD169. Three to five days
postinfection (100% cytopathic effect), cells were fixed and stained in immunofluorescence assays with the pp65-specific MAb 65-8 (A), MAb 28-19 (B), or polyclonal
guinea pig serum against bacterially expressed pp65 (C). Cos7 cells transfected with a vector expressing pp65 (D) or an EGFP-pp65 fusion protein (E and F) were fixed
and stained with MAb 28-19 (D only). Magnifications: (A to C) 3400; (D to F) 31,000.
FIG. 2. HCMV-encoded structural and nonstructural proteins are retained
in the nuclear matrix of HCMV AD169-infected human fibroblasts. Nuclei from
AD169-infected HF were isolated by treatment with nonionic detergent and then
treated with DNase and high salt to remove soluble components from the
nuclear matrix fraction. (A) Nuclear matrix-containing filters were probed with
MAbs specific for gB, IE1, IE2, ppUL44, ppUL69, pp28, MCP, and pp65. (B)
Filters containing proteins from nuclear matrix fractions washed with 1 M gua-
nidine hydrochloride prior to electrophoretic separation were probed with the
antibodies listed above. Sizes are indicated in kilodaltons.
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and 52-kDa forms of pp65 during the guanidine hydrochloride
wash (Fig. 3; Table 1), suggesting that these products were not
as strongly retained as the full-length protein. Consistent with
our findings shown in Fig. 2, the IE-1 protein was not enriched
in the nuclear matrix fraction and was contained in the soluble
fraction (Fig. 3).
To further examine the compartmentalization of virion
structural components on the nuclear matrix, we performed
immunofluorescence assays of in situ-extracted, HCMV-in-
fected HF. These assays were also used to estimate the quan-
tity of protein removed during the extraction procedure. As
shown in Fig. 4A, the IE-1 protein was readily detected in fixed
cells but not in extracted cytoskeletal frameworks following
treatment with high salt and DNase (Fig. 4B). The absence of
IE-1 in in situ-extracted cells confirmed the results of the
Western blot analysis which suggested that a significant
amount of IE-1 was not retained on the nuclear matrix. In
contrast, ppUL44, MCP, ppUL69, and pp65 were retained in
the insoluble nuclear matrix fraction (Fig. 4D, F, H, and J,
respectively). Furthermore, the pattern of immunofluores-
cence suggested that these proteins were localized to sub-
nuclear structures and not evenly distributed throughout the
nucleus. In addition, we observed the retention in the nuclear
matrix of the minor capsid protein (pUL85) and the small
capsid protein, p12 (pUL48/49) (data not shown). Note the
lack of reactivity of primary and secondary antibodies with
uninfected cells which were present in these preparations dem-
onstrating the specificity of these MAbs.
The tegument phosphoprotein pp65 binds to the nuclear
matrix. The interaction between pp65 and the nuclear matrix
could be explained by either a direct binding of pp65 to a
component of the nuclear matrix or an indirect binding
through an association with another virus-encoded protein
and/or DNase-resistant nucleic acid which was associated with
a protein component of the nuclear matrix. We initially ad-
dressed this question by examining the association of pp65 with
the nuclear matrix of cells infected with a recombinant vaccinia
virus expressing pp65. Recombinant pp65 expressed in the
absence of other HCMV-encoded proteins was enriched in the
nuclear matrix and 1 M guanidine hydrochloride-washed frac-
tions (Fig. 5). As a control for the extraction procedure, similar
experiments were performed with cells expressing a truncated
form of HCMV gB. We could not detect enrichment of the
130-kDa precursor form of this gB or of its 30-kDa cleavage
product in the nuclear matrix or guanidine hydrochloride-
washed pellets. These results indicated that pp65 was retained
in the nuclear matrix of cells in the absence of other viral proteins.
To directly investigate the specificity of the protein-protein
interactions between pp65 and nuclear matrix components, we
performed far-Western blotting with nuclear matrix material
derived from the human cell line HEp-2 as the substrate for
binding. A pp65 fusion protein containing a His6 tag at the
amino terminus was purified from E. coli and used to probe the
nitrocellulose membrane containing electrophoretically sepa-
rated nuclear matrix proteins. Binding of pp65 to the nuclear
matrix proteins was then detected with the pp65-specific MAb
28-19. The results of this experiment indicated a direct inter-
action between pp65 and at least three cellular proteins which
migrated between 50 and 70 kDa and two other proteins which
migrated at approximately 30 kDa (Fig. 6A, lane FW). Inter-
estingly, the 50- to 70-kDa bands were of the approximate
molecular size of nuclear lamins, which together represent
major protein constituents of the nuclear matrix.
In earlier experiments, we observed focal accumulations of
pp65 along the periphery of the nucleus (Fig. 1E and F).
Together, these findings were consistent with the association of
pp65 with proteins of the nuclear lamina, the protein network
which provides the structural framework of the nuclear enve-
lope (27, 47). Using a MAb against human lamin B1, we found
that the 68-kDa band detected in the far-Western blot comi-
grated with the 68-kDa band of the lamin B1 Western blot
(Fig. 6A, lane NA12). Together, these results suggested a di-
rect interaction between pp65 and proteins of the nuclear
matrix, possibly components of the nuclear lamina.
FIG. 3. Quantitative Western blots of nuclear matrix preparations from
AD169-infected HF. HCMV-infected cells were fractionated, and protein con-
tent in each fraction was determined as described in Materials and Methods.
Twenty-five micrograms of each of the fractions was loaded into the lanes (C,
cytoplasm, soluble protein; N, detergent-treated nuclei; NM, nuclear matrix
pellet; GW, guanidine hydrochloride-washed NM) and transferred to nitrocel-
lulose filters. Filters were reacted with MAb p63-27 against IE-1 (A) or MAb
28-19 against pp65 (B) and processed for autoradiography. Counts for each
fraction were determined on a PhosphorImager and were as follows: IE-1,
449,874.4, 13,951.6, 9,332.5, and 9,514.3 for C, N, NM, and GW fractions, re-
spectively; pp65 (68 kDa), 239,720.7, 2,048,547.0, 1,206,468.7, and 1,172,115.9 for
C, N, NM, and GW fractions, respectively; pp65 (50-kDa form), 33,155.2,
1,003,560.2, 774,609.0, and 188,991.4 for C, N, NM, and GW fractions, respec-
tively. Sizes are indicated in kilodaltons.
TABLE 1. Enrichment of pp65 on the nuclear matrix
Fractiona % Totalcellular proteinb
% of protein in fractionc
IE-1 pp65 (68 kDa) pp65 (50 kDa)
Cytoplasm/soluble protein 86.3 93.2 (1.08d) 5.1 (0.06) 1.7 (0.02)
Detergent-treated nuclei 8.9 2.9 (0.33) 43.9 (4.93) 50.2 (5.64)
Nuclear matrix 3.0 1.9 (0.63) 25.9 (8.63) 38.7 (12.94)
Guanidine-HCl-washed nuclear matrix 1.8 2.0 (1.11) 25.1 (13.94) 9.4 (5.22)
a HCMV-infected HF were fractionated into the indicated cellular fractions as described in Materials and Methods.
b The amount of total protein represented in each fraction was determined as described in Materials and Methods, and the percentage of total cellular protein was
calculated as follows: % 5 (total protein in fraction/total cellular protein) 3 100.
c The amount of IE-1, pp65 (68 kDa) or pp65 (50 kDa) in each fraction was determined by phosphorimaging. The results are presented as the percentage of total
IE-1, pp65 (68 kDa), or pp65 (50 kDa) in each fraction as calculated by the following formula: % 5 (counts in fraction/total counts for protein) 3 100.
d The specific enrichment of each protein in a specific fraction, determined by the following formula: enrichment 5 % of protein determined in footnote c/% of total
cellular protein determined in footnote b.
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pp65 interacts with lamins in the nuclear matrix fraction.
Direct investigations of protein-protein interactions with nu-
clear lamins have been complicated by the insolubility of
lamins. We approached the study of pp65 interactions with
these proteins by preparing soluble nuclear matrix proteins
through step dialysis of nuclear matrix extracts from AD169-
infected cells. The soluble nuclear matrix proteins were immu-
noprecipitated with a mixture of pp65-specific MAbs, and the
precipitated proteins were separated by SDS-PAGE and then
transferred to nitrocellulose membranes. The membranes were
probed with the anti-pp65 MAb 28-19, a polyvalent rabbit
antiserum specific for lamins (237) (29), and a control MAb,
28-21, which is specific for ppUL44. The pp65-specific MAb
detected pp65 and several forms of this protein (Fig. 6B). The
lamin-specific antiserum 237 detected lamins in the immuno-
precipitated complex (Fig. 6B). The immunoreactive pro-
tein(s) migrated at approximately 68 kDa, consistent with the
migration of lamins. Antiserum 237 failed to react with recom-
binant derived pp65 produced in bacteria, indicating that the
reactivity for lamins was specific (data not shown). In contrast,
MAb 28-21 reacted with three proteins which ranged in size
between 50 and 45 kDa (Fig. 6B). Although we cannot rule out
the possibility that at least one of these bands represents a
ppUL44-related protein, we observed the same three bands in
the membrane developed with the pp65-specific MAb, suggest-
ing that these proteins represented reactivity of the anti-mouse
IgG second antibody with the different forms of the immuno-
globulin heavy chain present in the original immunoprecipitate
(Fig. 6B). The identity of these bands was confirmed by prob-
ing a filter with rabbit anti-mouse IgG antibody (lane C), which
FIG. 4. Immunofluorescence assays of in situ-extracted, AD169-infected HF.
HF grown on glass coverslips were infected with HCMV AD169 5 days prior to
harvesting. Infected cells were untreated (A, C, E, G, and I) or extracted with
detergent, DNase, and high salt (B, D, F, H, and J) before fixation with 2.5%
paraformaldehyde. Coverslips were then reacted with MAbs specific for IE-1 (A
and B), ppUL44 (C and D), MCP (E and F), ppUL69 (G and H), or pp65 (I and
J). Antibody binding was detected with FITC-conjugated goat anti-mouse IgG
antibody and recorded by conventional fluorescence microscopy. Magnification
for all frames is 3348.
FIG. 5. pp65 expressed by recombinant vaccinia virus vv-pp65 is retained in
the nuclear matrix of infected BSC-1 monkey cells. Cytoplasmic (C), nuclear (N),
nuclear matrix (NM), and guanidine-washed nuclear matrix (GW) fractions were
prepared from recombinant vaccinia virus vv-Eco V gb (A)- or vv-pp65 (B)-
infected BSC-1 cells as described in Materials and Methods. The samples (10 mg
per lane) were analyzed by Western blotting using a gB-specific or pp65-specific
MAb and developed with 125I-protein A. Sizes are indicated in kilodaltons.
FIG. 6. pp65 binds to a nuclear matrix protein which comigrates with lamin
B1 in vitro. (A) Nuclear matrix material was isolated from the human carcinoma
cell line HEp-2 as described in Materials and Methods. Proteins were electro-
phoretically separated and then blotted onto nitrocellulose. Filters were then
reacted with pp65-specific MAb 28-19 (lane C), purified pp65 followed by anti-
pp65 MAb 28-19 (lane FW), or anti-lamin B1 MAb NA12 (lane NA12). Anti-
body binding was detected by addition of anti-mouse IgG antibody followed by
125I-protein A and autoradiography. Migration of molecular mass markers is
shown in kilodaltons at the left. (B) Coprecipitation of pp65 and lamins from
soluble nuclear matrix extracts. Soluble nuclear matrix extracts prepared from
AD169-infected HF were immunoprecipitated with MAbs against pp65. Immu-
noprecipitated proteins were separated by SDS-PAGE and transferred to nitro-
cellulose for Western blotting with antibodies specific for pp65 (28-19), lamins
(237), and a control MAb specific for ppUL44 (28-21). Antibody binding was
detected by addition of rabbit anti-mouse IgG antibody (lanes 28-19 and 28-21
only) followed by 125I-protein A and autoradiography. Immunoglobulin heavy
chains were detected with a rabbit anti-mouse immunoglobulin antibody fol-
lowed by addition of 125I-protein A and autoradiography (lane C). Migration of
the molecular mass marker (in kilodaltons) and immunoglobulin heavy chains
(Hc) is shown in the margins.
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produced the same pattern of reactivity as the control anti-
ppUL44 antibody. Together with our findings from the far-
Western analysis, these findings indicated that pp65 interacted
directly with lamins.
To further examine the interactions between pp65 and
lamins, in situ-extracted AD169-infected HF were reacted with
an anti-pp65 MAb and a rabbit polyclonal serum against
lamins a and c (17). We observed localization of pp65 along the
periphery of the nucleus of infected cells (Fig. 7A). Similarly,
the distribution of lamins a and c along the nuclear periph-
ery was consistent with previous studies (Fig. 7B) (17, 29).
As shown in Fig. 7C, we noted colocalization of pp65 and
lamins a and c. We also examined HCMV-infected HF late
in infection when extensive cytopathic effects were present.
In some cells, we observed extranuclear, vacuole-like struc-
tures containing both pp65 and lamin b (Fig. 7D to F).
These results were consistent with the biochemical data
suggesting a direct interaction between pp65 and proteins of
the nuclear lamina.
DISCUSSION
In this report, we have described the subcellular distribution
of several structural and nonstructural proteins of HCMV.
Specifically, we have investigated the intranuclear localization
of protein components of the virion tegument and capsid.
Because these proteins were colocalized in a specific nuclear
structure, the nuclear matrix, we have proposed that the nu-
clear matrix is a potential site of particle morphogenesis in the
HCMV-infected cell.
Intranuclear compartmentalization of proteins from several
DNA viruses has been well documented. Studies of adenovi-
rus-infected cells have described the spatial separation of viral
transcription and replication sites (51). Virus-encoded proteins
involved in replication of the adenovirus genome have been
localized to discrete nuclear structures which are distinct from
sites of transcription. de Bruyn Kops and Knipe (18) as well as
other groups (41, 42, 44) described the spatial organization of
viral replication structures in HSV-infected cells and suggested
that the arrangement of these structures was defined by pre-
existing nuclear architecture (18, 44). Similarly, intranuclear
HCMV replication compartments were recently characterized
by Sarisky and Hayward, who characterized the viral proteins
associated with the formation of these sites and for oriLyt-
dependent DNA replication (59). A more complete descrip-
tion of intranuclear compartmentalization of HSV proteins
was recently reported by Ward et al., who described HSV
structures within the nucleus which they termed assemblons
(64). These nuclear subcompartments were reported to segre-
gate proteins into groups associated with specific functions
including replication of viral DNA and assembly of subviral
particles. The mechanisms driving accumulation of proteins
into these structures are not clear, but they are likely to involve
interaction of viral proteins with the architectural framework
of the nucleus, thereby providing spatial organization to an
already temporally regulated replicative process.
FIG. 7. Colocalization of pp65 and lamins. Nuclear matrix-extracted (A to C) or unextracted (D to F) HCMV-infected cells were stained with a murine MAb against
pp65 (green; A and D) and a rabbit antiserum against lamins a and c (red; B) or against lamin b (red; E). Colocalization (blue) of pp65 and lamins is shown in panels
C and F. Magnification for all panels, 3890.
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Previous studies of several DNA viruses have also shown
that virion structural proteins localized to the nuclear matrix
(5, 7, 37, 66). Recent studies have documented the presence of
newly synthesized adenovirus virions on the core filaments of
the nuclear matrix, suggesting that this nuclear structure may
be a site of adenovirus assembly (66). In this same study,
Zhonghe et al. suggested that newly formed adenovirus parti-
cles track along 10-nm core filaments of the nuclear matrix,
providing some evidence that this filamentous network may
also provide a function critical to nuclear egress of progeny
virions. HSV proteins have been reported to associate with the
nuclear matrix (5, 7). In these studies, proteins comigrating
with capsid and DNA-binding proteins of HSV were found in
the nuclear matrix fraction (7). In addition, HSV capsids were
observed in a filamentous network within the nucleus (5).
These findings, together with studies which have shown that
the nuclear matrix is an important site of transcription and
replication, were consistent with a model in which this nuclear
compartment could serve as the site of assembly for viruses
which encapsidate nucleic acid in the nucleus (7, 37, 66). Our
findings were also in agreement with these previous findings in
adenovirus- and HSV-infected cells and suggested that HCMV
may also assemble subviral particles in association with the
nuclear matrix of infected cells. However, finding virion struc-
tural proteins associated with the nuclear matrix does not in-
dicate that in each case there is a direct interaction between
individual viral proteins and proteins of the nuclear matrix. In
some cases the association could have resulted from virion
protein interactions with a limited number of virus-encoded
proteins bound to the nuclear matrix; however, the mainte-
nance of this association following washes in 1 M guanidine
hydrochloride suggested a very stable interaction.
We focused the majority our studies on the tegument pro-
tein pp65 because of its abundance in extracellular particles as
well as its nuclear expression shortly after infection of permis-
sive fibroblasts (36, 61). Previous studies have shown that al-
most immediately after infection, pp65 is transported to the
nucleus of fibroblasts, where it accumulates until late in infec-
tion (61, data not shown). Targeting of the protein has been
attributed to a bipartite nuclear targeting signal at the extreme
carboxy terminus of the molecule (61) and more recently to a
second signal proximal to this conventional nuclear localiza-
tion signal (NLS) (26). However, in both of these studies,
mutated forms of pp65 which lacked these signals could still be
localized to the nucleus when expressed in recombinant sys-
tems, suggesting that there were other domains mediating nu-
clear localization of pp65. Such domains could mediate nuclear
retention in addition to nuclear localization associated with
previously described NLS (26, 61). As shown in Fig. 1, pp65
was observed in subnuclear structures and also in patches
along the periphery of the nucleus. Additional domains within
pp65 could therefore mediate retention on a particular nuclear
structure such as the nuclear lamina. Such protein interactions
could explain the findings of earlier studies which documented
the nuclear accumulation of mutant forms of pp65 which
lacked NLS but were of such a size as to allow passive diffusion
into and out of the nucleus (20, 26, 61).
The nuclear matrix of HCMV-infected fibroblasts was iso-
lated by the method of Mirkovitch et al., which consisted of
high-salt extraction of DNase-treated nuclei which were ini-
tially isolated by nonionic detergent treatment of viable cells
(45). The resulting pellet of nuclear material represented in-
soluble nuclear proteins and was essentially devoid of DNA.
Western blot analysis of nuclear matrix material demonstrated
the retention of several HCMV structural proteins which have
previously been characterized as nuclear proteins (Fig. 2A). In
addition, the polymerase accessory protein ppUL44 and the
associated products of this open reading frame were also
present in the nuclear matrix pellet. In contrast, the nuclear
72-kDa IE-1 and 86-kDa IE-2 nonstructural proteins were not
detected in this assay, suggesting that the association of
HCMV proteins with the nuclear matrix was specific. Further-
more, we failed to detect two abundant tegument proteins,
pp28 (ppUL99) and pp150 (ppUL32), as well as glycoprotein B
(gpUL55) in the nuclear matrix, providing additional evidence
for the specificity of the protein-nuclear matrix interactions
that we have described (data not shown). These results were
confirmed by immunofluorescence of in situ-extracted HCMV-
infected cells (Fig. 4). Together, these data suggested that
several proteins which were incorporated into nuclear subviral
particles were sequestered on the nuclear matrix.
Enrichment of pp65 on the nuclear matrix was demonstrated
by quantitative Western blotting (Fig. 3; Table 1). The results
from this experiment suggest that pp65 is strongly associated
with the nuclear matrix. Moreover, the localization of pp65 to
the nuclear matrix in the absence of other HCMV proteins
indicated a direct interaction with components of the nuclear
matrix. Although initial studies also documented the associa-
tion of pp65 with the nuclear matrix of monkey cells (Fig. 5)
and insect cells (data not shown), we obtained additional evi-
dence of the direct interaction of pp65 with the nuclear matrix
by performing far-Western blotting with recombinant-derived
pp65 and the nuclear matrix of HEp-2 cells (Fig. 6A). The
results of this experiment indicated that pp65 associated with a
limited number of protein constituents of the nuclear matrix.
The binding of pp65 to a restricted set of nuclear matrix pro-
teins underscored the specificity of the protein-protein inter-
actions and suggested the possibility of a sequence-specific
targeting signal for the localization of pp65 to the nuclear
matrix. Although the identities of the nuclear matrix proteins
detected by far-Western blotting have not been conclusively
established, the higher-molecular-weight bands were similar in
molecular size to lamins a, b, and c, which together represent
major protein components of the nuclear matrix (27, 47).
Western blot analysis of the nuclear matrix protein-containing
filter showed that one of the proteins detected by far-Western
blotting comigrated with lamin B1 (Fig. 6A). Additional bio-
chemical evidence for the interaction between pp65 and lamins
was provided by the coprecipitation of pp65 and lamins from a
soluble extract of nuclear matrix proteins from HCMV-in-
fected fibroblasts (Fig. 6B). The polymerase accessory protein
ppUL44 was not coprecipitated with pp65 and lamins, suggest-
ing that this was a specific interaction (Fig. 6B). Thus, the
binding of pp65 to a major constituent of the nuclear matrix
and colocalization of pp65 and lamins (Fig. 7) were consistent
with the hypothesis that at least one step in nuclear tegumen-
tation of the HCMV capsid might localize to this subnuclear
compartment. Finally, we have consistently observed cytoplas-
mic vacuole-like structures containing pp65 and nuclear lamins
in cells transfected with pp65 expression plasmids which are
similar to those illustrated in Fig. 7D and E. This observation
and the accumulation of pp65 on the nuclear membrane sug-
gest a possible role of pp65 in focal modifications of the nu-
clear envelope.
In summary, we have provided biochemical and imaging
data of the association of nuclear tegument and capsid proteins
of HCMV with the nuclear matrix. Together, these findings
argued for the nuclear matrix being a potential site for assem-
bly of subviral particles of HCMV and suggested that protein-
protein interactions between virus-encoded proteins and this
nuclear structure might provide spatial coordination for the
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highly regulated and temporally coordinated replication of this
virus.
ACKNOWLEDGMENTS
We thank Robert Goldman and Nilabh Chaudhary for the generous
gifts of antibody 237 and for the rabbit sera against lamins a/c and b,
respectively. We also thank Amy Sears (Department of Microbiology,
Emory University, Atlanta, Ga.) for assistance with the confocal mi-
croscopic analysis and Scott Swindle and Kenneth Fish for technical
advice and helpful discussions. We thank Dana Pinson for assistance
with preparation of the manuscript.
P.C.A. was supported by training grant NIH T32 AI07150 and by
grant NIH R01 AI20408 to J.A.E. V.S. was supported by a grant
supplement to NIH R01 AI30105 and R01 AI35602 to W.J.B.
REFERENCES
1. Andreoni, M., M. Faircloth, L. Vugler, and W. Britt. 1989. A rapid micro-
neutralization assay for the measurement of neutralizing antibody reactive
with human cytomegalovirus. J. Virol. Methods 23:157–168.
2. Angeletti, P. C., and J. A. Engler. 1996. Tyrosine kinase dependent release of
an adenovirus preterminal protein complex from the nuclear matrix. J. Virol.
70:3060–3067.
3. Baldick, C. J., and T. Shenk. 1996. Proteins associated with purified human
cytomegalovirus particles. J. Virol. 70:6097–6105.
4. Benko, D. M., and W. Gibson. 1986. Primate cytomegalovirus glycoproteins:
lectin-binding properties and sensitivities to glycosidases. J. Virol. 59:703–
713.
5. Ben-Ze’Ev, A., R. Abulafia, and S. Bratosin. 1983. Herpes simplex virus and
protein transport are associated with the cytoskeletal framework and the
nuclear matrix in infected BSC-1 cells. Virology 129:501–507.
6. Berezney, R., M. J. Mortillaro, H. Ma, X. Wei, and J. Samarandu. 1995. The
nuclear matrix: a structural milieu of genomic function. Int. Rev. Cytol.
162A:1–65.
7. Bibor-Hardy, V., M. Pouchelet, E. St-Pierre, M. Herzberg, and R. Simard.
1982. The nuclear matrix is involved in herpes simplex virogenesis. Virology
121:296–306.
8. Blencowe, B. J., R. Issner, J. Kim, P. McCaw, and P. A. Sharp. 1995. New
proteins related to the ser-arg family of splicing factors. RNA 1:852–865.
9. Boppana, S. B., and W. J. Britt. 1996. Recognition of human cytomegalovi-
rus gene products by HCMV-specific cytotoxic T cells. Virology 222:293–296.
10. Bridge, E., M. Carmo-Fonseca, A. Lamond, and U. Petterson. 1993. Nuclear
organization of splicing small nuclear ribonucleoproteins in adenovirus-in-
fected cells. J. Virol. 67:5792–5802.
11. Britt, W. J., and D. Auger. 1986. Synthesis and processing of the envelope
gp55-116 complex of human cytomegalovirus. J. Virol. 58:185–191.
12. Britt, W. J., and L. Vugler. 1987. Structural and immunological character-
ization of the intracellular forms of an abundant 68,000 Mr human cytomeg-
alovirus protein. J. Gen. Virol. 68:1897–1907.
13. Britt, W. J., L. Vugler, E. J. Butfiloski, and E. B. Stephens. 1990. Cell surface
expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of
HCMV-recombinant vaccinia virus infected cells in analysis of the human
neutralizing antibody response. J. Virol. 64:1079–1085.
14. Carvalho, T., J.-S. Seeler, K. Ohman, P. Jordan, U. Petterson, G. Akusjarvi,
M. Carmo-Fonseca, and A. Dejean. 1995. Targeting of adenovirus E1A and
E4-ORF3 proteins to nuclear matrix-associated PML bodies. J. Cell Biol.
131:45–56.
15. Chabot, B., S. Bisotto, and M. Vincent. 1995. The nuclear matrix phospho-
protein p255 associates with splicing complexes as part of the [U4/U6.U5]
tri-snRNP particle. Nucleic Acids Res. 23:3206–3213.
16. Chang, Y. E., and B. Roizman. 1993. The product of the UL31 gene of
herpes simplex virus 1 is a nuclear phosphoprotein which partitions with the
nuclear matrix. J. Virol. 67:6348–6356.
17. Chaudhary, N., and J.-C. Courvalin. 1993. Stepwise reassembly of the nu-
clear envelope at the end of mitosis. J. Cell Biol. 122:295–306.
18. de Bruyn Kops, A., and D. M. Knipe. 1994. Preexisting nuclear architecture
defines the intranuclear location of herpesvirus DNA replication structures.
J. Virol. 68:3512–3526.
19. Di Lazzaro, C., G. Campadelli-Fiume, and M. R. Torrisi. 1995. Intermediate
forms of glycoconjugates are present in the envelope of herpes simplex
virions during their transport along the exocytic pathway. Virology 214:619–
623.
20. Dingwall, C., and R. A. Laskey. 1986. Protein import into the cell nucleus.
Annu. Rev. Cell Biol. 2:367–390.
21. Doucas, V., A. M. Ishov, A. Romo, H. Juguilon, M. D. Weitzman, R. M.
Evans, and G. G. Maul. 1996. Adenovirus replication is coupled with the
dynamic properties of the PML nuclear structure. Genes Dev. 10:196–207.
22. Durfee, T., M. A. Mancini, D. Jones, S. J. Elledge, and W.-H. Lee. 1994. The
amino-terminal region of the retinoblastoma gene product binds a novel
nuclear matrix protein that colocalizes to centers for RNA-processing. J. Cell
Biol. 127:609–622.
23. Fey, E. G., and S. Penman. 1988. Nuclear matrix proteins reflect cell type of
origin in cultured human cells. Proc. Natl. Acad. Sci. USA 85:121–125.
24. Fish, K. N., and J. A. Nelson. Unpublished results.
25. Fredman, J. N., and J. A. Engler. 1993. Adenovirus precursor to terminal
protein interacts with the nuclear matrix in vivo and in vitro. J. Virol.
67:3384–3395.
26. Gallina, A., E. Percivalle, L. Simoncini, M. G. Revello, G. Gerna, and G.
Milanesi. 1996. Human cytomegalovirus pp65 lower matrix phosphoprotein
harbours two transplantable nuclear localization signals. J. Gen. Virol. 77:
1151–1157.
27. Gerace, L., and B. Burke. 1988. Functional organization of the nuclear
envelope. Annu. Rev. Cell Biol. 4:335–374.
28. Getzenberg, R. H. 1994. Nuclear matrix and the regulation of gene expres-
sion: tissue specificity. J. Cell. Biochem. 55:22–31.
29. Goldman, A. E., R. D. Moir, M. Montag-Lowy, M. Stewart, and R. D.
Goldman. 1992. Pathway of incorporation of microinjected lamin A into the
nuclear envelope. J. Cell Biol. 119:725–735.
30. Granzow, H., F. Weiland, A. Jons, B. G. Klupp, A. Karger, and T. C.
Mettenleiter. 1997. Ultrastructural analysis of the replication cycle of pseu-
dorabies virus in cell culture: a reassessment. J. Virol. 71:2072–2082.
31. Greenfield, I., J. Nickerson, S. Penman, and M. Stanley. 1991. Human
papillomavirus 16 E7 protein is associated with the nuclear matrix. Proc.
Natl. Acad. Sci. USA 88:11217–11221.
32. Guo, B., P. R. Odgren, A. J. Van Wijnen, T. J. Last, J. Nickerson, S. Penman,
J. B. Lian, J. L. Stein, and G. S. Stein. 1995. The nuclear matrix protein
NMP-1 is the transcription factor YY1. Proc. Natl. Acad. Sci. USA 92:
10526–10530.
33. He, D., J. A. Nickerson, and S. Penman. 1990. Core filaments of the nuclear
matrix. J. Cell Biol. 110:569–580.
34. Hensel, G., H. Meyer, S. Ga¨rtner, G. Brand, and H. F. Kern. 1995. Nuclear
localization of the human cytomegalovirus tegument protein pp150 (UL32).
J. Gen. Virol. 76:1591–1601.
35. Hozac, P., A. B. Hassan, D. A. Jackson, and P. R. Cook. 1993. Visualization
of replication factories attached to a nucleoskeleton. Cell 73:361–373.
36. Irmiere, A., and W. Gibson. 1983. Isolation and characterization of a non-
infectious virion-like particle released from cells infected with human strains
of cytomegalovirus. Virology 30:118–133.
37. Khittoo, G., L. Delorme, C. V. Dery, M. L. Tremblay, J. M. Weber, V.
Bibor-Hardy, and R. Simard. 1986. Role of the nuclear matrix in adenovirus
maturation. Virus Res. 5:391–403.
38. Landini, M. P., B. Severi, G. Furlini, and L. Badiali De Giorgi. 1987. Human
cytomegalovirus structural components: intracellular and intraviral localiza-
tion of p28 and p65-69 by immunoelectron microscopy. Virus Res. 8:15–23.
39. Lauber, A. H., N. P. Sandhu, M. Schuchard, M. Subramanian, and T. C.
Spelsberg. 1995. Nuclear matrix acceptor binding sites for steroid hormone
receptors: a candidate nuclear matrix acceptor protein. Int. Rev. Cytol.
162B:337–375.
40. Liao, H., R. J. Winkfein, G. Mack, J. B. Rattner, and T. J. Yen. 1995.
CENP-F is a protein of the nuclear matrix that assembles onto kinetochores
at late G2 and is rapidly degraded after mitosis. J. Cell Biol. 130:507–518.
41. Liptak, L., S. L. Uprichard, and D. M. Knipe. 1996. Functional order of
assembly of herpes simplex virus DNA replication proteins into prereplica-
tive site structures. J. Virol. 70:1759–1767.
42. Lukonis, C. J., and S. K. Weller. 1996. Characterization of nuclear structures
in cells infected with herpes simplex virus type 1 in the absence of viral DNA
replication. J. Virol. 70:1751–1758.
43. Mancini, M., B. Shan, J. A. Nickerson, S. Penman, and W.-H. Lee. 1994. The
retinoblastoma gene product is a cell cycle-dependent, nuclear matrix-asso-
ciated protein. Proc. Natl. Acad. Sci. USA 91:418–422.
44. Maul, G. G., A. M. Ishov, and R. D. Everett. 1996. Nuclear domain 10 as
preexisting potential replication start site of herpes simplex virus type-1.
Virology 217:67–75.
45. Mirkovitch, J., M. E. Mirault, and U. K. Laemmli. 1984. Organization of the
higher-order chromatin loop: specific DNA attachment sites on the nuclear
scaffold. Cell 39:223–232.
46. Mocarski, E. S. 1996. Cytomegaloviruses and their replication, p. 2447–2492.
In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick,
T. P. Monath, B. Roizman, and S. E. Strauss (ed.), Fields virology, 3rd ed.
Lippincott-Raven Publishers, Philadelphia, Pa.
47. Newport, J. W., and D. J. Forbes. 1987. The nucleus: structure, function, and
dynamics. Annu. Rev. Biochem. 56:535–565.
48. Nickerson, J. A., B. Blencowe, and S. Penman. 1995. The architectural
organization of nuclear metabolism. Int. Rev. Cytol. 162A:67–123.
49. Pienta, K. J., and C. N. Hoover. 1994. Coupling of cell structure to cell
metabolism and function. J. Cell. Biochem. 55:16–21.
50. Plachter, B., W. Britt, R. Vornhagen, T. Stamminger, and G. Jahn. 1993.
Analysis of proteins encoded by IE regions 1 and 2 of human cytomegalo-
virus using monoclonal antibodies generated against recombinant antigens.
Virology 193:642–652.
51. Pombo, A., J. Ferreira, E. Bridge, and M. Carmo-Fonseca. 1994. Adenovirus
replication and transcription sites are spatially separated in the nucleus of
infected cells. EMBO J. 13:5075–5085.
3328 SANCHEZ ET AL. J. VIROL.
52. Radha, V., S. Nambirajan, and G. Swarup. 1996. Association of Lyn tyrosine
kinase with the nuclear matrix and cell cycle-dependent changes in matrix-
associated tyrosine kinase activity. Eur. J. Biochem. 23:352–359.
53. Roffman, E., J. P. Albert, J. P. Goff, and N. Frenkel. 1990. Putative site for
the acquisition of human herpesvirus 6 virion tegument. J. Virol. 64:6308–
6313.
54. Roizman, B. 1996. Herpesviridae, p. 2221–2230. In B. N. Fields, D. M. Knipe,
P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and
S. E. Strauss (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers,
Philadelphia, Pa.
55. Roizman, B., and D. Furlong. 1974. The replication of herpesviruses, p.
229–403. In H. Fraenkel-Conrat and R. R. Wagner (ed.), Comprehensive
virology, vol. 3. Plenum Press, New York, N.Y.
56. Roizman, B., and A. E. Sears. 1996. Herpes simplex viruses and their repli-
cation, p. 2231–2295. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M.
Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Strauss (ed.),
Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
57. Rose, J. K., L. Buonocore, and M. A. Whitt. 1991. A new liposome reagent
mediating nearly quantitative transfection of animal cells. Bio/Technology
10:520–525.
58. Sanchez, V., K. Greis, Y. Akimoto, G. Hart, and W. J. Britt. 1996. Assembly
of HCMV tegument occurs in different cellular compartments. In Abstracts
from the 21st Herpesvirus Workshop.
59. Sarisky, R. T., and G. S. Hayward. 1996. Evidence that the UL84 gene
product of human cytomegalovirus is essential for promoting oriLyt-depen-
dent DNA replication and formation of replication compartments in cotrans-
fection assays. J. Virol. 70:7398–7413.
60. Schirmbeck, R., and W. Deppert. 1989. Nuclear subcompartmentalization of
simian virus 40 large T antigen: evidence for in vivo regulation of biochem-
ical activities. J. Virol. 63:2308–2316.
61. Schmolke, S., P. Drescher, G. Jahn, and B. Placter. 1995. Nuclear targeting
of the tegument protein pp65 (UL83) of human cytomegalovirus: an unusual
bipartite nuclear localization signal functions with other portions of the
protein to mediate its efficient nuclear transport. J. Virol. 69:1071–1078.
62. Stein, G. S., A. J. van Wijnen, J. L. Stein, J. B. Lian, J. P. Bidwell, and M.
Montecino. 1994. Nuclear architecture supports integration of physiological
regulatory signals for transcription of cell growth and tissue-specific genes
during osteoblast differentiation. J. Cell. Biochem. 55:4–15.
63. Ward, P. L., D. E. Barker, and B. Roizman. 1996. A novel herpes simplex
virus 1 gene, UL43.5, maps antisense to the UL43 gene and encodes a protein
which colocalizes in nuclear structures with capsid proteins. J. Virol. 70:
2684–2690.
64. Ward, P. L., W. O. Ogle, and B. Roizman. 1996. Assemblons: nuclear struc-
tures defined by aggregation of immature capsids and some tegument pro-
teins of herpes simplex virus 1. J. Virol. 70:4623–4631.
65. Winkler, M., S. A. Rice, and T. Stamminger. 1994. UL69 of human cyto-
megalovirus, an open reading frame with homology to ICP27 of herpes
simplex virus, encodes a transactivator of gene expression. J. Virol. 68:3943–
3954.
66. Zhonghe, Z., J. A. Nickerson, G. Krochmalnic, and S. Penman. 1987. Alter-
ations in nuclear matrix structure after adenovirus infection. J. Virol. 61:
1007–1018.
VOL. 72, 1998 HCMV STRUCTURAL PROTEINS LOCALIZE TO NM 3329
 
